The asialoglycoprotein receptor-mediated gene transfer system is a useful method for targeted gene transfer to liver cells. This system is based on the finding that hepatocytes have a specific receptor for asialoglycoprotein. The efficiency of this system, however, is very low. To enhance the efficiency of this system,we examined the effect of a fusogenic peptide from influenza virus on asialoglycoprotein receptor-mediated gene transfer. It is known that this peptide disrupts the endosomal membrane at acidic pH, and allows DNA to escape from the endosome into the cytosol before attack by lysosomes. A recombinant plasmid DNA carrying a reporter gene was complexed with a poly-L-lysine-conjugated 23-residue peptide derived from influenza virus hemagglutinin HA2 N-terminal peptide and galactose-poly-L-lysine conjugate, and added to the culture of HepG2 cells. When the fusogenic peptide was incorporated into the DNA complex with the galactose-poly-L-lysine conjugate, the luciferase activity in the HepG2 cells was more than 500-fold higher than that of cells transfecred with the DNA complex without the peptide. An antibody against the asialoglycoprotein receptor blocked the transfer of the DNA complex, indicating that the DNA complex was specifically transferred into the HepG2 cells by asialoglycoprotein receptor-mediated endocytosis. Our results suggest that the asialoglycoprotein receptor-mediated gene delivery system using this fusogenic peptide may be useful for the development of gene therapy targeting the liver.
Receptor-mediated endocytosis is the process by which cells specifically bind and internalize a variety of macromolecules or ligands. The ligand binds to a specific receptor at the cell surface and is internalized via a specialized pathway. In most cases, the ultimate fate of the ligand is delivery to lysosomes and subsequent degradation. The asialoglycoprotein receptor on the sinus side of hepatocytes recognizes galactose-terminal glycoprotein in serum and internalizes the ligand into the cytosol for degradation. Wu and Wu were the first to take advantage of this feature for gene targeting to hepatocytes in the development of hepatic gene therapy [1] . They introduced complexes of plasmid DNA with asialoorosomucoid-poly-L-lysine conjugate into hepatoma cells by asialoglycoprotein receptor-mediated endocytosis. A similar strategy has been used to transfer DNA to cells that express the transferrin receptor [2] . This gene transfer system affords the advantages of targeting a specific cell that expresses a unique receptor without the use of infectious virus vectors which may pose a safety risk. The major disadvantages of this system are the transient and low-level expression of the transgene for therapeutic applications. It has been hypothesized that one of the causes of this low efficiency is a consequence of the lysosomal attack and the resulting degradation of the internalized DNA complex. In the transferrin receptor-mediated gene transfer, Wagner et al. have taken synthetic fusogenic peptides derived from an influenza virus envelope protein and linked them to a complex containing plasmid DNA, transferrin, and polylysine [3] . They showed that the peptides enhanced the receptor-mediated gene transfer in a series of cell lines. It seems that the fusogenic peptides release the DNA complex from endosomes into the cytoplasm by disruption of the endosomal membrane at acidic pH, and rescue the DNA from lysosomal degradation. In the case of the influenza virus, the fusion activity has been extensively studied [4] [5] [6] . In the present study, we used this fusogenic peptide as part of the DNA complex for the enhancement of transgene expression in the asialoglycoprotein receptor-mediated gene transfer system. The efficiency of DNA transfer using DNA complexes containing this fusogenic peptide and galactose poly-L-lysine conjugates (Pep-pL and Gal-pL) resulted in a level of Iuciferase activity that was far greater than that achieved without the peptide. A similar study [7] has been published, however, the preparation of DNA complexes for transfection in the current study is simpler than that reported already. We also demonstrated asialoglycoprotein receptor-mediated gene transfer into HepG2 cells by using an asialoglycoprotein receptor antibody. These results suggest that this system might be useful for liver-specific gene transfer in vivo.
MATERIALS AND METHODS
Cell culture. The human hepatoma cell line HepG2 and human cervix epithelioid carcinoma HeLa cell line were obtained from American Type Culture Collection (Rockville, MD). Cells were grown (at 3TC, 5% C02) in DMEM medium (GIBCO, Reufrewshire, UK) supplemented with 10% fetal calf serum (FCS) (GIBCO). Plasmid DNA. The plasmid RSVLUC containing the firefly luciferase gene under the control of the Rous-sarcoma virus long terminal repeat enhancer/ promoter was used as a reporter of gene transfer.
Fusogenic peptide. The fusogenic peptide with the sequence GLFEAIAGFI-ENGWEGMIDGGGC and the non-fusogenic peptide with the same amino acid composition as the fusogenic peptide, but with the scrambled sequence FLGIAE-AIDIGNGWEGMEFGGGC, both of which were characterized by Wagner et al., were used [3] . These peptides were synthesized by TANA-Bio-Systems Co. (Houston, TX).
Preparation of conjugates. Gal-pL conjugate was prepared as described except that 20 mM HEPES saline buffer, pH 7.3 (HBS) was used as the dialysis buffer [8] . Poly-L-lysine hydrobromide (p7890; Sigma, St. Louis, MO) and a-Dgalactopyranosyl phenylisothiocyanate (G-3266, Sigma) were used in this preparation. Galactose content (17 mol) per mol of poly-L-lysine was determined by the resorcinol sulfuric acid micromethod [9] . Poly-L-lysine was also peptidylated essentially as described earlier [10] . In brief, 3 mg of succinylated poly-L-lysine (p4283, Sigma), 10 mg of peptide, and 6 mg of carbodiimide (1769, Sigma) were dissolved in 1 ml of HBS, and the mixture was stirred for 24 h at room temperature. It was then dialyzed in Spectra-par dialysis tubing (Spectrum Medical Industries, Houston, TX) against a large volume of HBS for 2 days. Preceding the reaction, the fusogenic peptide and the non-fusogenic peptide were dissolved in 20 mM NaPi, the pH was adjusted to 8.0, and then the solution was subjected to gel filtration on a Sephadex G 10 (Pharmacia, Uppsala, Sweden) column in order to change the buffer. Peptide content in the conjugate was determined by absorbance at 280 nm.
Formation of DNA complex and transfection. DNA complexes were prepared by adding dropwise a solution of 3 )cg of plasmid DNA in 175 pl of HBS to a solution of 3-12 pg of Gal-pL conjugate with or without 1.5-6pg of Pep-pL conjugate in 75 pl of HBS. The mixture was kept for 30 min at room temperature. Cells were plated at a density of 5 x 105 per well in 12-well tissue culture plates. Before the complex was added to the cells, the medium was replaced with DMEM containing 1% FCS. Two-hundred-fifty microliters of DNA complex solution was then added to each well. After a 4-h incubation at 3TC, the medium was changed to fresh complete DMEM medium containing 10% FCS. The cells were incubated for an additional 72 h at 3TC, and assayed for luciferase activity in triplicate. In a blocking experiment with antibody, 2.5 p g of human asialoglycoprotein receptor monoclonal antibody (Daiichi Pure Chemicals, Tokyo) or LDL receptor monoclonal antibody (Progen Biotechnik GMBH, Heidelberg, Germany) was added to the transfection medium.
Luciferase activity assay. The cells in each well were washed twice with PBS and lysed for 15 min at room temperature in 100,1 of PicaGene Reporter Lysis Buffer, PGC-50 (Toyo Ink Mfg., Tokyo). The lysates were centrifuged at l5,000 x g for 15 min, and 10 pl of the supernatant was mixed with 400 pl of dilution buffer containing 125 mlvt potassium phosphate buffer (pH 7 .8), 12.5 mm MgClz, and 6.25 mm ATP. Luciferase activity was monitored for 10 s in a luminometer , AutoLumat LB953 (EG&G Berthold, Bad Wildbad , Germany) with automatic injection of 100 pl of 1 mm luciferin (Wako Pure Chemicals, Osaka). Protein content of the supernatant was determined by the Bradford method [11] . Luciferase activity was determined as relative light units (RLU)/mg protein (mean±SE) .
RESULTS
Optimization of Gal-pL conjugate to DNA ratio for targeted gene transfer For determination of the optimal conditions for DNA complex formation , various amounts of Gal-pL conjugate were added to 3-pg aliquots of plasmid DNA. After an incubation for 30 min at room temperature , the DNA complexes were tested by agarose gel electrophoresis and a transfection experiment into HepG2 cells. In the retardation assay of the conjugate-DNA complex in agarose gel, a Gal-pL conjugate to DNA ratio of 0.4/1 (w/w) or greater resulted in complete retardation of the complexed DNA (Fig. 1) .
To test the efficiency of transfection, we added various amount of Gal-pL conjugate to 3 pg of DNA, and then transfected HepG2 or HeLa cells with these DNA complexes. The most effective ratio of conjugate to DNA yielding maximal luciferase activity was 3/1 (w/w) (Fig. 2) . This optimal ratio of conjugate to DNA was comparable to that when lactosylated poly-L-lysine conjugate was used [12] .
Effect of influenza fusogenic peptide on gene transfer
To study the optimal concentration of fusogenic peptide on transfection efficiency, we made complexes with a constant amount of Gal-pL conjugate (9 pg in 250 pl) and an increasing amount of Pep-pL conjugate (0-6 pg as peptide) . The highest luciferase activity in the extract of HepG2 after transfection was detected when 9 pg of Gal-pL conjugate and 3 pg of Pep-pL conjugate were complexed with 3pg of plasmid DNA. The addition of Pep-pL conjugate into DNA complexes maximally increased (by 546 times) the transfection efficiency (Fig. 3) . The non-fusogenic peptide did not enhance the gene expression. The addition of 68 pug (75 pM) of chloroquine to the incubation medium improved the expression 19-fold over that in the absence of chloroquine. These results demonstrate the enhancement of transgene expression by the fusogenic peptide. (Fig. 2) . The specific uptake of the DNA complex by HepG2 cells was also tested in a blocking experiment using an asialoglycoprotein receptor antibody. Before incubation with the DNA complex, HepG2 cells were incubated with the asialoglycoprotein receptor antibody or with an LDL receptor antibody for 30 min. The asialoglycoprotein receptor antibody reduced the expression more than 90% in the HepG2 cells, whereas the LDL receptor antibody did not (Fig. 4) . The entrance of poly-L-lysine DNA complex without ligand was not blocked by the asialoglycoprotein receptor antibody. These results show that the DNA complex was specifically taken up by asialoglycoprotein receptor-mediated endocytosis.
Time-course analysis of gene expression
The expression of the luciferase gene was measured at 24, 48, 72, and 120 h after transfection of HepG2 cells with Gal-Pep-pL conjugate-DNA complex. The maximum expression was found after 72 h, but the activity was no longer detectable after 120 h (Fig. 5) . Thus, the gene expression was transient, as was reported earlier [13] . [14] . However, these vectors have some problems including a lack of target cell specificity, limitation in the size of transgene, and safety considerations. As an alternative to viral systems, nonviral gene transfer vehicles including receptor-mediated gene transfer systems have also been developed [14] . In particular, regarding liver-specific gene targeting, asialoglycoprotein receptor-mediated gene transfer is an excellent delivery system because of the unique receptor on the cell surface of hepatocytes and their natural uptake of macromolecules. In this study, we used galactose conjugated with poly-L-lysine as a ligand for the asialoglycoprotein receptor, which is a galactose residue-specific receptor existing on the hepatocyte surface. Compared with asialoorosomucoid or asialofetuin, the use of galactose for cell recognition has the following advantages. First, galactose is easily conjugated with poly-L-lysine by a well-established PTC method. Second, it was reported that galactosylated poly-L-lysine allowed the formation of a smaller and more uniform DNA complex, which was preferentially taken up by hepatocytes but not Kupffer cells [8] . Third, the use of galactose might reduce the immunogenicity of the DNA complex in vivo applications. Lactosylated poly-L-lysine has also been successfully used for targeted gene transfer as shown by Midoux et al. [12] and Martinez-Fong et al. [15] . In our study, the blocking experiment using the human asialoglycoprotein receptor antibody directly confirmed that the DNA complexes were specifically transferred by asialoglycoprotein receptor-mediated endocytosis. We also showed that the poly-L-lysine DNA complex without ligand was taken up by with DNA complex (31ag as DNA) with fusogenic peptide (3 ,ug as peptide) were removed at the times indicated and assayed for luciferase activity.
non-specific endocytosis, because the antibody had no effect on the transfer of the complex. Although receptor-mediated gene transfer is cell type specific, it is still not efficient enough for therapeutic application. Efficient gene transfer has been tried by the addition of acidotropic agents such as chloroquine [16] or endosome membrane destabilizing agents such as adenoviral particles [17] or fusogenic peptides [3, 7, 12, 18, 19] . In this study, we chose the fusogenic peptide of influenza virus for enhancement of the transgene efficiency, because both chloroquine and adenoviral particles might be toxic for in vivo application. The fusogenic protein best characterized to date is influenza virus hemagglutinin (HA). Murata et al. [4] and Lear and DeGrado [5] synthesized peptides corresponding to the N-terminal segment of influenza hemagglutinin HA2 and demonstrated that the peptide possessed fusion activity at acidic pH. The first application of the fusogenic peptide to receptor-mediated gene transfer was tried by Wagner et al. [3] . Using synthesized peptides containing the sequences of the 20 N-terminal residues of HA2, they showed that the presence of the peptide in the DNA complex renders the complexes active in membrane disruption in a liposome leakage assay and results in a substantial augmentation of the transferrin/polylysine-mediated gene transfer. We used the influenza fusogenic peptide characterized by Wagner et al. for the asialoglycoprotein receptor-mediated gene transfer into HepG2 cells. As a result, 3 jig of the peptide in the DNA complex enhanced the transfer of the DNA into the cells by more than 500-fold, by promoting endosome lysis. This result was comparable with the result of Plank et al. [7] . Fusogenic peptides incorporated into a DNA complex may thus be suitable for in vivo application. The peptides in medium have also augmented the efficiency of the transgene into hepatoma cells [12] . In the present study, 10 nM DNA as DNA complex was used for the transfection. Preparations at higher concentrations resulted in precipitation of the DNA complex because of the neutralization of the DNA charge by poly-L-lysine. Since higher concentrations of DNA complex solution are required for in vivo application, the solubility of the DNA complex must be improved. One option is the use of a hetero-polymer containing poly-L-lysine and other amino acids with a hydrophilic group.
